JP2022533340A5 - - Google Patents
Info
- Publication number
- JP2022533340A5 JP2022533340A5 JP2021567913A JP2021567913A JP2022533340A5 JP 2022533340 A5 JP2022533340 A5 JP 2022533340A5 JP 2021567913 A JP2021567913 A JP 2021567913A JP 2021567913 A JP2021567913 A JP 2021567913A JP 2022533340 A5 JP2022533340 A5 JP 2022533340A5
- Authority
- JP
- Japan
- Prior art keywords
- fluorocyclopropyl
- imidazo
- oxadiazole
- carboxamide
- methylphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/086582 | 2019-05-13 | ||
| CN2019086582 | 2019-05-13 | ||
| PCT/CN2020/090060 WO2020228746A1 (en) | 2019-05-13 | 2020-05-13 | Crystalline forms of n- (5- (5- ( (1r, 2s) -2-fluorocyclopropyl) -1, 2, 4-oxadiazol-3-yl) -2-methylphenyl) imidazo [1, 2-a] pyridine-3-carboxamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022533340A JP2022533340A (ja) | 2022-07-22 |
| JP2022533340A5 true JP2022533340A5 (enExample) | 2023-06-02 |
Family
ID=73289607
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021567913A Pending JP2022533340A (ja) | 2019-05-13 | 2020-05-13 | Ｎ－（５－（５－（（１Ｒ，２Ｓ）－２－フルオロシクロプロピル）－１，２，４－オキサジアゾール－３－イル）－２－メチルフェニル）イミダゾ［１，２－ａ］ピリジン－３－カルボキサミドの結晶形態 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220194936A1 (enExample) |
| EP (1) | EP3969453A4 (enExample) |
| JP (1) | JP2022533340A (enExample) |
| KR (1) | KR20220007650A (enExample) |
| CN (1) | CN114096538A (enExample) |
| AU (1) | AU2020274564A1 (enExample) |
| BR (1) | BR112021022685A2 (enExample) |
| CA (1) | CA3139552A1 (enExample) |
| IL (1) | IL287877A (enExample) |
| MA (1) | MA55976A (enExample) |
| MX (1) | MX2021013814A (enExample) |
| SG (1) | SG11202112281UA (enExample) |
| TW (1) | TW202108581A (enExample) |
| WO (1) | WO2020228746A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023534963A (ja) * | 2020-07-15 | 2023-08-15 | サード ハーモニック バイオ， インコーポレイテッド | 選択的ｃ－ｋｉｔキナーゼ阻害剤の結晶質形態 |
| TW202237096A (zh) * | 2020-11-19 | 2022-10-01 | 瑞士商諾華公司 | 選擇性ｃ－ｋｉｔ激酶抑制劑之醫藥組合物及其製造及使用方法 |
| TW202237097A (zh) * | 2020-11-19 | 2022-10-01 | 美商第三諧波生物公司 | 選擇性ｃ－ｋｉｔ激酶抑制劑之醫藥組合物及其製造及使用方法 |
| EP4626884A1 (en) | 2022-11-30 | 2025-10-08 | Blueprint Medicines Corporation | N-phenyl-pyrazolo[1,5-a]pyridine-3-carboxamide derivatives as wild type c-kit kinase inhibitors for the treatment of urticaria |
| CN122580315A (zh) * | 2024-01-04 | 2026-08-14 | 上海翰森生物医药科技有限公司 | 多环类衍生物抑制剂、其制备方法和应用 |
| WO2025256609A1 (en) * | 2024-06-13 | 2025-12-18 | Third Harmonic Bio, Inc. | Crystalline forms of a selective c-kit kinase inhibitor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2845785A1 (en) * | 2011-09-01 | 2013-03-07 | Irm Llc | Compounds and compositions as c-kit kinase inhibitors |
| CN103930424A (zh) * | 2011-09-01 | 2014-07-16 | Irm责任有限公司 | 作为c-Kit激酶抑制剂的化合物和组合物 |
| US8569283B2 (en) * | 2011-09-01 | 2013-10-29 | Valentina Molteni | Compounds and compositions as c-Kit kinase inhibitors |
| US9199981B2 (en) * | 2011-09-01 | 2015-12-01 | Novartis Ag | Compounds and compositions as C-kit kinase inhibitors |
-
2020
- 2020-05-13 TW TW109115939A patent/TW202108581A/zh unknown
- 2020-05-13 EP EP20805948.5A patent/EP3969453A4/en not_active Withdrawn
- 2020-05-13 SG SG11202112281UA patent/SG11202112281UA/en unknown
- 2020-05-13 CN CN202080050607.4A patent/CN114096538A/zh active Pending
- 2020-05-13 AU AU2020274564A patent/AU2020274564A1/en not_active Abandoned
- 2020-05-13 BR BR112021022685A patent/BR112021022685A2/pt not_active IP Right Cessation
- 2020-05-13 KR KR1020217040220A patent/KR20220007650A/ko not_active Ceased
- 2020-05-13 MX MX2021013814A patent/MX2021013814A/es unknown
- 2020-05-13 JP JP2021567913A patent/JP2022533340A/ja active Pending
- 2020-05-13 CA CA3139552A patent/CA3139552A1/en active Pending
- 2020-05-13 MA MA055976A patent/MA55976A/fr unknown
- 2020-05-13 WO PCT/CN2020/090060 patent/WO2020228746A1/en not_active Ceased
- 2020-05-13 US US17/595,260 patent/US20220194936A1/en not_active Abandoned
-
2021
- 2021-11-07 IL IL287877A patent/IL287877A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2752319C (en) | Tosylate salt of a 5-pyrazolyl-2-pyridone derivative, useful in the treatment of copd | |
| JP5894153B2 (ja) | ニロチニブ塩及びそれらの結晶性形態 | |
| JP2026048795A (ja) | Ｌｎｐ０２３の結晶形態 | |
| JP5552121B2 (ja) | ロイコトリエン産生のインドリジン阻害剤 | |
| JP2026031970A (ja) | Ｇｌｐ－１受容体アゴニストの結晶形ａおよびその調製法 | |
| WO2024206339A1 (en) | Quinolinone amide compounds and uses thereof | |
| CN114096538A (zh) | N-(5-(5-((1r,2s)-2-氟环丙基)-1,2,4-噁二唑-3-基)-2-甲基苯基)咪唑并[1,2-a]吡啶-3-甲酰胺的结晶型 | |
| US20110183999A1 (en) | Novel polymorphic forms of methyl carbamate | |
| TWI834634B (zh) | 醫藥化合物、其鹽類、其製劑及其等之製備和使用之方法 | |
| JP2018522945A5 (enExample) | ||
| TWI765086B (zh) | Parp-1抑制劑的晶型及其製備方法 | |
| US20120316183A1 (en) | Novel solvates of methylcarbamate | |
| JP6818031B2 (ja) | モルホリン誘導体の塩、結晶形、その製造方法、これらを含む医薬組成物およびその用途 | |
| JP2021529175A5 (enExample) | ||
| WO2020156162A1 (zh) | Mek抑制剂及其在医药上的应用 | |
| KR102802551B1 (ko) | 1-설포닐 피롤 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물 | |
| JP2022530889A (ja) | ジアミノピリミジン化合物又はその水和物の固体形態、その調製方法及びその適用 | |
| JP2021522348A5 (enExample) | ||
| KR20150054860A (ko) | 포스파티딜이노시톨 3-키나아제 억제제의 정제 제형 | |
| CN116354956A (zh) | 维利西呱晶型及其制备方法 | |
| WO2017175854A1 (ja) | １，５－ベンゾジアゼピン化合物の結晶 | |
| TW202600558A (zh) | 醛固酮合成酶抑制劑之固體形式 | |
| KR20260002254A (ko) | 이미다조[1,2-a]피리딘 화합물의 신규 염의 결정형 및 이의 제조방법 | |
| JP2007514744A (ja) | ２，３−ジメチル−８−（２，６−ジメチルベンジルアミノ）−Ｎ−ヒドロキシエチル−イミダゾ［１，２−ａ］ピリジン−６−カルボキシアミドメシラート塩の新規な結晶形 | |
| KR20260002253A (ko) | 이미다조[1,2-a]피리딘 화합물의 신규 염 및 이의 제조방법 |